Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383669919> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4383669919 abstract "Abstract Background and Aims Acute severe ulcerative colitis [ASUC] is a medical emergency treated with intravenous steroids followed by infliximab or cyclosporin in the case of steroid failure with emergent colectomy required in refractory or severe cases. Case series have reported on the effectiveness of tofacitinib for refractory disease, but data regarding the effectiveness of upadacitinib in this setting have not been previously reported. We describe the use of upadacitinib therapy for steroid-refractory ASUC in patients with prior loss of response to infliximab. Methods Six patients who received upadacitinib for steroid-refractory ASUC were identified at two Australian tertiary inflammatory bowel disease centres. Patients were followed for up to 16 weeks after discharge with clinical, biochemical and intestinal ultrasound [IUS] outcomes. Results All six patients demonstrated clinical response to upadacitinib induction during their inpatient admission. Four patients achieved corticosteroid-free clinical remission by week 8, including complete resolution of rectal bleeding and transmural healing assessed by IUS, and sustained clinical remission at week 16. One patient proceeded to colectomy at week 15 due to refractory disease. No adverse events directly attributable to upadacitinib were identified. Conclusions Upadacitinib may have a role as a safe and effective salvage therapy for steroid-refractory ASUC in patients who have previously failed to respond to infliximab therapy. Prospective studies are required to determine the safety and efficacy of upadacitinib use in this setting before routine use can be recommended." @default.
- W4383669919 created "2023-07-09" @default.
- W4383669919 creator A5019013403 @default.
- W4383669919 creator A5045806536 @default.
- W4383669919 creator A5062042129 @default.
- W4383669919 creator A5080037678 @default.
- W4383669919 creator A5085738790 @default.
- W4383669919 date "2023-07-09" @default.
- W4383669919 modified "2023-09-27" @default.
- W4383669919 title "Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis" @default.
- W4383669919 cites W2085161424 @default.
- W4383669919 cites W2106136830 @default.
- W4383669919 cites W2111362292 @default.
- W4383669919 cites W2143710323 @default.
- W4383669919 cites W2171789845 @default.
- W4383669919 cites W3115410759 @default.
- W4383669919 cites W3164964548 @default.
- W4383669919 cites W3174304322 @default.
- W4383669919 cites W4281674067 @default.
- W4383669919 cites W4317360141 @default.
- W4383669919 doi "https://doi.org/10.1093/ecco-jcc/jjad115" @default.
- W4383669919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37422724" @default.
- W4383669919 hasPublicationYear "2023" @default.
- W4383669919 type Work @default.
- W4383669919 citedByCount "0" @default.
- W4383669919 crossrefType "journal-article" @default.
- W4383669919 hasAuthorship W4383669919A5019013403 @default.
- W4383669919 hasAuthorship W4383669919A5045806536 @default.
- W4383669919 hasAuthorship W4383669919A5062042129 @default.
- W4383669919 hasAuthorship W4383669919A5080037678 @default.
- W4383669919 hasAuthorship W4383669919A5085738790 @default.
- W4383669919 hasBestOaLocation W43836699191 @default.
- W4383669919 hasConcept C121332964 @default.
- W4383669919 hasConcept C126322002 @default.
- W4383669919 hasConcept C141071460 @default.
- W4383669919 hasConcept C142424586 @default.
- W4383669919 hasConcept C197934379 @default.
- W4383669919 hasConcept C2776667177 @default.
- W4383669919 hasConcept C2776694085 @default.
- W4383669919 hasConcept C2777138892 @default.
- W4383669919 hasConcept C2778260677 @default.
- W4383669919 hasConcept C2779134260 @default.
- W4383669919 hasConcept C2780479503 @default.
- W4383669919 hasConcept C2780775027 @default.
- W4383669919 hasConcept C71924100 @default.
- W4383669919 hasConcept C87355193 @default.
- W4383669919 hasConcept C90924648 @default.
- W4383669919 hasConceptScore W4383669919C121332964 @default.
- W4383669919 hasConceptScore W4383669919C126322002 @default.
- W4383669919 hasConceptScore W4383669919C141071460 @default.
- W4383669919 hasConceptScore W4383669919C142424586 @default.
- W4383669919 hasConceptScore W4383669919C197934379 @default.
- W4383669919 hasConceptScore W4383669919C2776667177 @default.
- W4383669919 hasConceptScore W4383669919C2776694085 @default.
- W4383669919 hasConceptScore W4383669919C2777138892 @default.
- W4383669919 hasConceptScore W4383669919C2778260677 @default.
- W4383669919 hasConceptScore W4383669919C2779134260 @default.
- W4383669919 hasConceptScore W4383669919C2780479503 @default.
- W4383669919 hasConceptScore W4383669919C2780775027 @default.
- W4383669919 hasConceptScore W4383669919C71924100 @default.
- W4383669919 hasConceptScore W4383669919C87355193 @default.
- W4383669919 hasConceptScore W4383669919C90924648 @default.
- W4383669919 hasLocation W43836699191 @default.
- W4383669919 hasLocation W43836699192 @default.
- W4383669919 hasOpenAccess W4383669919 @default.
- W4383669919 hasPrimaryLocation W43836699191 @default.
- W4383669919 hasRelatedWork W2022030441 @default.
- W4383669919 hasRelatedWork W2027117135 @default.
- W4383669919 hasRelatedWork W2039430653 @default.
- W4383669919 hasRelatedWork W2056746318 @default.
- W4383669919 hasRelatedWork W2063965078 @default.
- W4383669919 hasRelatedWork W2122325622 @default.
- W4383669919 hasRelatedWork W2172472108 @default.
- W4383669919 hasRelatedWork W2236217792 @default.
- W4383669919 hasRelatedWork W2620912143 @default.
- W4383669919 hasRelatedWork W4206728214 @default.
- W4383669919 isParatext "false" @default.
- W4383669919 isRetracted "false" @default.
- W4383669919 workType "article" @default.